title: MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia.
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Joshua N
authors.initials: JN
authors.lastname: Gustine
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Meid
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Zachary R
authors.initials: ZR
authors.lastname: Hunter
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Lian
authors.initials: L
authors.lastname: Xu
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.|Department of Medicine, Harvard Medical School, Boston, MA, USA.
authors.forename: Steven P
authors.initials: SP
authors.lastname: Treon
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.|Department of Medicine, Harvard Medical School, Boston, MA, USA.
authors.forename: Jorge J
authors.identifier: 0000-0001-9490-7532
authors.initials: JJ
authors.lastname: Castillo
mesh_terms: D020022:Genetic Predisposition to Disease; D006801:Humans; D009154:Mutation; D053594:Myeloid Differentiation Factor 88 / Q000235:genetics*; D016066:Pleural Effusion, Malignant / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy; D011379:Prognosis; D008258:Waldenstrom Macroglobulinemia / Q000150:complications* / Q000235:genetics* / Q000628:therapy
chemical_list: D053594:Myeloid Differentiation Factor 88
keywords: 
  MYD88
  ; Waldenström macroglobulinaemia; pleural effusion